» Articles » PMID: 38350939

Very low-calorie Ketogenic Diet (VLCKD) in the Management of Hidradenitis Suppurativa (Acne Inversa): an Effective and Safe Tool for Improvement of the Clinical Severity of Disease. Results of a Pilot Study

Abstract

Background: Hidradenitis suppurativa (HS), an inflammatory-based dermatological condition often associated with obesity, poses significant challenges in management. The very low-calorie ketogenic diet (VLCKD) has shown efficacy in addressing obesity, related metabolic disorders, and reducing chronic inflammation. However, its effects on HS remain underexplored. In this prospective pilot study, we aimed to investigate the impact of a 28-day active phase of VLCKD on HS in a sample of treatment-naive women with HS and excess weight.

Methods: Twelve women with HS and overweight or obesity (BMI 27.03 to 50.14 kg/m), aged 21 to 54 years, meeting inclusion/exclusion criteria and agreeing to adhere to VLCKD, were included. Baseline lifestyle habits were assessed. The Sartorius score was used to evaluate the clinical severity of HS. Anthropometric parameters (waist circumference, weight, height, and body mass index), body composition via bioelectrical impedance analysis, levels of trimethylamine N-oxide (TMAO), oxidized low-density lipoprotein (oxLDL), and derivatives of reactive oxygen metabolites (dROMs) were assessed at baseline and after 28 days of the active phase of VLCKD.

Results: VLCKD led to general improvements in anthropometric parameters and body composition. Notably, a significant reduction in the Sartorius score was observed after the intervention (Δ%: - 24.37 ± 16.64, p < 0.001). This reduction coincided with significant decreases in TMAO (p < 0.001), dROMs (p = 0.001), and oxLDL (p < 0.001) levels. Changes in the Sartorius score exhibited positive correlations with changes in TMAO (p < 0.001), dROMs (p < 0.001), and oxLDL (p = 0.002).

Conclusion: The 28-day active phase of VLCKD demonstrated notable improvements in HS severity and associated metabolic markers, highlighting the potential utility of VLCKD in managing HS and its association with metabolic derangements in women with overweight or obesity.

Citing Articles

Beyond the skin: endocrine, psychological and nutritional aspects in women with hidradenitis suppurativa.

Dattolo A, Torres M, Frias-Toral E, Paganelli A, Zhang M, Madonna S J Transl Med. 2025; 23(1):167.

PMID: 39930474 PMC: 11809040. DOI: 10.1186/s12967-025-06175-1.


Supplementation with essential amino acids in the early stage of carbohydrate reintroduction after a very-low energy ketogenic therapy (VLEKT) improves body cell mass, muscle strength and inflammation.

Annunziata G, Verde L, DOrsi V, Caprio M, Gorini S, Savastano S J Transl Med. 2025; 23(1):111.

PMID: 39849571 PMC: 11761218. DOI: 10.1186/s12967-024-06037-2.


The Impact of Diet on Hidradenitis Suppurativa Severity: A Cross-Sectional Case-Control Study.

Kesik F, Dogan-Gunaydin S, Fisunoglu M Medicina (Kaunas). 2025; 60(12.

PMID: 39768986 PMC: 11678350. DOI: 10.3390/medicina60122107.


Clinical Evaluation of Extract Combinations for Effective Hangover Relief in Humans.

Lee K, Xu G, Paik D, Shim Y, Reaney M, Park I Foods. 2025; 13(24.

PMID: 39766963 PMC: 11675335. DOI: 10.3390/foods13244021.


Unlocking the Mechanisms of Hidradenitis Suppurativa: Inflammation and miRNA Insights.

Ames E, Sanders M, Jacobs M, Vida T Clin Cosmet Investig Dermatol. 2024; 17:2829-2846.

PMID: 39677852 PMC: 11646389. DOI: 10.2147/CCID.S483871.


References
1.
Bettoli V, Naldi L, Cazzaniga S, Zauli S, Atzori L, Borghi A . Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry. Br J Dermatol. 2015; 174(1):195-7. DOI: 10.1111/bjd.13864. View

2.
Muscogiuri G, Barrea L, Di Somma C, Altieri B, Vecchiarini M, Orio F . Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study. Hormones (Athens). 2019; 18(1):75-84. DOI: 10.1007/s42000-018-0090-9. View

3.
Iamele L, Fiocchi R, Vernocchi A . Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med. 2002; 40(7):673-6. DOI: 10.1515/CCLM.2002.115. View

4.
Vazquez B, Alikhan A, Weaver A, Wetter D, Davis M . Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2012; 133(1):97-103. PMC: 3541436. DOI: 10.1038/jid.2012.255. View

5.
Canoui-Poitrine F, Revuz J, Wolkenstein P, Viallette C, Gabison G, Pouget F . Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009; 61(1):51-7. DOI: 10.1016/j.jaad.2009.02.013. View